# Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections

> **NCT01142934** · PHASE4 · UNKNOWN · sponsor: **Catholic University of the Sacred Heart** · enrollment: 1200 (estimated)

## Conditions studied

- Catheterization
- Infection

## Interventions

- **DEVICE:** Transparent adhesive dressing with an integrated gel pad containing 2% w/w chlorhexidine gluconate (CHG) (TegaDerm CHG)

## Key facts

- **NCT ID:** NCT01142934
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-10
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2012-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01142934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01142934, "Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01142934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*